Open access · CC-BY
via OpenAlex
SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
R. Manjula, Kumari Anuja, Francisco Javier Alcain
Frontiers in Pharmacology · 2021 · ▲ 195 citations
Abstract
dependent histone deacetylases (HDAC) that play a pivotal role in neuroprotection and cellular senescence(definition). SIRT1-7 are different homologs from sirtuins. They play a prominent role in many aspects of physiology and regulate crucial proteins. Modulation of sirtuins can thus be utilized as a therapeutic target for metabolic disorders. Neurological diseases have distinct clinical manifestations but are mainly age-associated and due to loss of protein homeostasis. Sirtuins mediate several life extension pathways and brain functions that may allow therapeutic intervention for age-related diseases. There is compelling evidence to support the fact that SIRT1 and SIRT2 are shuttled between the nucleus and cytoplasm and perform context-dependent functions in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). In this review, we highlight the regulation of SIRT1 and SIRT2 in various neurological diseases. This study explores the various modulators that regulate the activity of SIRT1 and SIRT2, which may further assist in the treatment of neurodegenerative disease. Moreover, we analyze the structure and function of various small molecules that have potential significance in modulating sirtuins, as well as the technologies that advance the targeted therapy of neurodegenerative disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fphar.2020.585821
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Manjula, R., Anuja, K., & Alcain, F.J. (2021). SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2020.585821
Vancouver
Manjula R, Anuja K, Alcain FJ. SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases. Frontiers in Pharmacology. 2021. doi:10.3389/fphar.2020.585821.
BibTeX
@article{r2021SIRTan,
title = {SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases},
author = {R. Manjula and Kumari Anuja and Francisco Javier Alcain},
journal = {Frontiers in Pharmacology},
year = {2021},
doi = {10.3389/fphar.2020.585821},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomedicines 2023
Open access · CC-BY
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Frontiers in Pharmacology 2025
Open access · CC-BY
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
Assistance Publique Hopitaux De Marseille 2025
Open access · US-GOV
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
EMBO Molecular Medicine 2013
Open access · CC-BY
SIRT1 and SIRT2: emerging targets in neurodegeneration
Biochemistry (Moscow) 2021
Citation only
Mitochondrial Disorders in Alzheimer’s Disease
International Journal of Molecular Sciences 2023
Open access · CC-BY